LEADERSHIP:

EXECUTIVE COMMITTEE

Our Executive Committee has expertise in all aspects of drug discovery and development

Kathy Giusti

Founder and Chief Executive Officer

Kathy Giusti founded the Multiple Myeloma Research Foundation (MMRF) in 1998, shortly after being diagnosed with multiple myeloma. In 2004, she founded then Multiple Myeloma Research Consortium. Previous to this, Ms. Giusti, a senior pharmaceutical executive with more than 15 years in the industry, last served as Executive Director of as G.D. Searle & Co.’s worldwide arthritis franchise. She has received several awards for her efforts to accelerate research and drug development, including the Centennial Medal for Distinguished Public Service from the American Association for Cancer Research, the Partners in Progress Award from the American Society of Clinical Oncology, the Healthcare Businesswomen's Association's Woman of the Year Award, and Harvard Business School Entrepreneurial Award. She serves on the National Cancer Advisory Board, an appointment she received from President Bush, and is a member of the Board of Directors for IMS Health. Ms. Giusti received her MBA in general management from Harvard Business School and graduated from the University of Vermont.

Susan L. Kelley, MD

Chief Medical Officer

Dr. Kelley has more than 20 years of experience in oncology clinical research and drug development within the pharmaceutical industry. She most recently served as Vice President of Global Clinical Development for Oncology at Bayer Healthcare Pharmaceuticals. Previous to this, she held several leadership positions in Bristol-Myers Squibb's (BMS) Oncology Therapeutic Area. She received her medical degree from Duke University School of Medicine. She completed her certification in Internal Medicine at University of Colorado followed by Medical Oncology training at the Dana-Farber Cancer Institute in Boston.

Louise M. Perkins, PhD

Chief Scientific Officer

Dr. Perkins is responsible for the strategic development and execution of the MMRF's research agenda. Dr. Perkins brings to the MMRF more than 16 years of pharmaceutical research experience from two pharmaceutical companies. Prior to joining the MMRF, she was the Director of Cancer Research at Bayer Pharmaceuticals. Previous to this, she led a cancer research group at the Schering Plough Research Institute. She graduated from the University of Michigan with a PhD and MS in biological chemistry and conducted postdoctoral studies at Princeton University in the Department of Molecular Biology. She earned her BS in zoology from the University of North Carolina at Chapel Hill.

Steven J. Amelio

Chief Financial Officer

Steven Amelio is an accomplished financial leader with more than 25 years of experience in management and operations, including significant experience in the healthcare and medical device industries. Before joining the MMRF, he most recently served as Vice President and Divisional CFO of Surgical Devices with Covidien in Norwalk, Conn. Prior to this, he held senior executive positions at Tyco Healthcare Group and United States Surgical Corporation, both in Norwalk, Conn. He received his Masters in Business Administration from Iona College in New Rochelle, N.Y.

Anne Quinn Young, MPH

Vice President, Communications

Anne Quinn Young oversees all communications as well as educational programming for and outreach to healthcare professionals and patients. Prior to joining the MMRF, she was a consultant in the Healthcare Practice of Datamonitor, and previously worked in healthcare public relations at Burson-Marsteller and Chandler Chicco Agency. She has a Master of Public Health from the Mailman School of Public Health of Columbia University, received her Bachelor of Arts from Dartmouth College, and completed a postgraduate internship at the Department of Justice, Antitrust Division.

Robert C. Lucas

Vice President, Development

Rob Lucas joined the MMRF in 2009, and brings over 22 years of revenue development experience to the organization. As Vice President, Corporate Relations for the American Cancer Society, Rob developed nationwide strategies for building relationships with Corporate America to increase the reach and affect of income development, volunteerism, cancer control and mission awareness programs. He most recently served as Senior Vice President, Revenue Development for the March of Dimes, overseeing over $200 million in annual Special Events, Cause Marketing and Major Gift revenue. He is a graduate of Rowan University.